Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
EVH Stock Chart & Stats
$2.73
<$0.01(0.08%)
At close: 4:00 PM EST
$2.73
<$0.01(0.08%)
Day’s Range― - ―
52-Week Range$2.69 - $12.07
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.78M
Market Cap
$304.67M
Enterprise Value$1.27B
Total Cash (Recent Filing)$116.65M
Total Debt (Recent Filing)$1.08B
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Feb 24, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding111,600,850
10 Day Avg. Volume3,290,513
30 Day Avg. Volume2,777,213
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)1.29
Price to Sales (P/S)0.51
P/FCF Ratio-210.54
Enterprise Value/Market Cap4.17
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit3.36
Enterprise Value/Ebitda106.96
Forecast
1Y Price Target
$8.10Price Target Upside196.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)0.31
Revenue Forecast (FY)$2.39B
Bulls Say, Bears Say
Bulls Say
Contract Restructuring And Technology InitiativesRestructuring of risk contracts alongside AI investments and margin maturation is expected to reduce earnings volatility and underpin longer-term EBITDA expansion, analysts indicate.
Legislation And SubsidiesPotential congressional action to extend or enhance ACA subsidies and curb surprise premium hikes could ease exchange enrollment pressure and trigger a relief rally, analysts say.
New Business Wins And PipelineLarge recent contract wins combined with a healthy sales pipeline position the company to convert demand into meaningful revenue growth and support a recovery in earnings, analysts note.
Bears Say
Exchange Enrollment UncertaintyOngoing uncertainty around ACA exchange enrollments and the potential lack of enhanced subsidies poses downside risk to revenue and could keep shares under pressure, analysts warn.
Leverage And Balance-sheet RiskConcerns about elevated leverage and the company’s ability to manage debt heighten downside exposure if enrollment or cash flow trends weaken, analysts caution.
Medical Cost Spikes And Partner Data IssuesPast unexpected medical cost spikes and partner data problems significantly reduced EBITDA run rate, underscoring operational risks that could weigh on near-term profitability, analysts note.
Evolent Health News
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $2.69 and its highest was $12.06 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $304.67M.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Feb 24, 2026 which is in 12 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Nov 06, 2025. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.098 by -$0.048.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.05.
How many shares outstanding does Evolent Health have?
Evolent Health has 111,600,850 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.05 in its last earnings report, missing expectations of $0.098. Following the earnings report the stock price went down -17.333%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Evolent Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.10 (196.70% Upside)
$8.10 (196.70% Upside)
Blogger Sentiment
Neutral
EVH Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 788.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $38.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.28%
12-Months-Change
Fundamentals
Return on Equity
-13.63%
Trailing 12-Months
Asset Growth
-1.93%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
EVH Company Deck
EVH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Evolent's earnings call was largely positive, highlighting financial success and strategic growth through new contracts and partnerships. However, there are challenges related to potential membership reductions in exchange markets and uncertainties in the 2026 financial outlook.View all EVH earnings summariesEVH Stock 12 Month Forecast
Average Price Target
$8.10
▲(196.70% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---